Equity Development Investment Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Equity Development Investment Tbk. trades at Rp83 (market cap 1.31T, 1.33M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 28.1K 24h volume). The key difference: Equity Development Investment Tbk. is far larger — about 7.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Equity Development Investment Tbk. is more actively traded (1.33M versus 28.1K). Which is the better fit depends on your goals.
| GSMF | OBAT | |
|---|---|---|
Market Cap | 1.31T | 167.37B |
Volume | 1.33M | 28.1K |
Lot | 13.33K | 281 |
Turnover | 111.66M | 6.94M |
Average Price | 83.79 | 247.07 |
Value | 111.66M | 6.94M |
Indicative Equilibrium Price | 85 | 246 |
Indicative Equilibrium Volume | 6.5K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Read more on GSMF →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →